Clinical Trial Update: Mirabegron in Parkinson Disease and Impaired Cognition [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on mirabegron in Parkinson disease and impaired cognition with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Cognition
• Overactive Bladder
• Parkinson Disease

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: HealthPartners Institute | Conditions: Parkinson Disease, Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2019-05-08